Diagnosed only if considered: isolated renal mucormycosis

Renal mucormycosis requires a triple integrated approach to prevent systemic dissemination of the fungus: antifungals (amphotericin B and posaconazole are the only systemic antifungal drugs with activity against mucorales), surgical debridement of the infected tissue (nephrectomy), and treatment of...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet (British edition) Vol. 385; no. 9984; p. 2322
Main Authors Dhaliwal, Harpal S, DM, Singh, Anupam, MB, Sinha, Saroj K, Dr, Nampoothiri, Ram V, MB, Goyal, Ajay, DM, Chatterjee, Debajyoti, MD, Dewana, Sudheer K, MCh, Lal, Anupam, MD, Das, Ashim, Prof, Gupta, K L, Prof, Kochhar, Rakesh, Prof
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 06.06.2015
Elsevier Limited
Subjects
Adult
Amphotericin B - therapeutic use
Antifungal Agents - therapeutic use
Fungal infections
Humans
Internal Medicine
Kidney - diagnostic imaging
Kidney Diseases - diagnosis
Kidney Diseases - microbiology
Kidney Diseases - pathology
Kidneys
Male
Medical diagnosis
Medical treatment
Mucormycosis - diagnosis
Mucormycosis - pathology
Pain
Pyelonephritis - diagnosis
Pyelonephritis - microbiology
Tomography, X-Ray Computed
Ultrasonic imaging
Urine
Online AccessGet full text

Cover

More Information
Summary:Renal mucormycosis requires a triple integrated approach to prevent systemic dissemination of the fungus: antifungals (amphotericin B and posaconazole are the only systemic antifungal drugs with activity against mucorales), surgical debridement of the infected tissue (nephrectomy), and treatment of any predisposing condition.1
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ObjectType-Article-1
ObjectType-Feature-2
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(15)60730-9